Coherus Biosciences | CHRS - Trade Creditors


Coherus Biosciences reported $13.17M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Akebia Therapeutics USD 9.42M 1.04M Jun/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amarin USD 18.8M 29.36M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
Baxter International USD 1.03B 52M Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Coherus Biosciences USD 13.17M 1.69M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Fujifilm JPY 292.7B 15.36B Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
Merck USD 3.83B 36M Jun/2026
Myriad Genetics USD 30.4M 2.2M Jun/2026
Pacira USD 17.51M 3.5M Jun/2026
Perrigo USD 400.4M 34.4M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026
Zoetis USD 452M 55M Jun/2026